Acrux Limited

概览 |  新闻 |  多媒体  | 研究

---

Acrux Limited 公司资料

Acrux is a specialty pharmaceutical company, developing and commercialising a range of patented, patient-preferred healthcare products for global markets, using its innovative technology to administer drugs through the skin. Acrux's product pipeline includes treatments of hormonal deficiencies, pain, central nervous system disorders and a contraceptive. Acrux has also licensed its technology to Eli Lilly for veterinary healthcare products.

公司详细信息

	传真	(03) 8379 0101
	主要部门	医疗-制药
	支柱产业	生物科技
	主页	www.acrux.com.au

---

Key Developments: Acrux Limited

	6月22日澳洲股市：打破跌势 JUNE 22, 2009 13:00 - 文章点击: 8,926 上周五，澳洲股市在一周之中首次收涨。基本指数S&P/ASX200 上涨 7.5 点, 或 0.19%, 报 3,899.6 点, 综合指数上涨 7 点, 或 0.18%, 报 3894.4 点。

11,336 公司背景浏览

本页浏览人次: (过去7日: 8) (过去30日: 43) (自发布以来: 1894)